Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 185

1.

Effect of myo-inositol and melatonin versus myo-inositol, in a randomized controlled trial, for improving in vitro fertilization of patients with polycystic ovarian syndrome.

Pacchiarotti A, Carlomagno G, Antonini G, Pacchiarotti A.

Gynecol Endocrinol. 2016;32(1):69-73. doi: 10.3109/09513590.2015.1101444. Epub 2015 Oct 28.

PMID:
26507336
2.

Management of women with PCOS using myo-inositol and folic acid. New clinical data and review of the literature.

Regidor PA, Schindler AE, Lesoine B, Druckman R.

Horm Mol Biol Clin Investig. 2018 Mar 2;34(2). pii: /j/hmbci.2018.34.issue-2/hmbci-2017-0067/hmbci-2017-0067.xml. doi: 10.1515/hmbci-2017-0067. Review.

PMID:
29498933
3.
5.

Randomized, double blind placebo-controlled trial: effects of myo-inositol on ovarian function and metabolic factors in women with PCOS.

Gerli S, Papaleo E, Ferrari A, Di Renzo GC.

Eur Rev Med Pharmacol Sci. 2007 Sep-Oct;11(5):347-54.

PMID:
18074942
6.

Pretreatment with myo-inositol in non polycystic ovary syndrome patients undergoing multiple follicular stimulation for IVF: a pilot study.

Lisi F, Carfagna P, Oliva MM, Rago R, Lisi R, Poverini R, Manna C, Vaquero E, Caserta D, Raparelli V, Marci R, Moscarini M.

Reprod Biol Endocrinol. 2012 Jul 23;10:52. doi: 10.1186/1477-7827-10-52.

7.

The combined therapy myo-inositol plus D-chiro-inositol, rather than D-chiro-inositol, is able to improve IVF outcomes: results from a randomized controlled trial.

Colazingari S, Treglia M, Najjar R, Bevilacqua A.

Arch Gynecol Obstet. 2013 Dec;288(6):1405-11. doi: 10.1007/s00404-013-2855-3. Epub 2013 May 25.

PMID:
23708322
8.

[Study on clinical effect on infertility women with polycystic ovary syndrome treated by in vitro maturation and in vitro fertilization-embryo transfer].

Yu R, Lin J, Zhao JZ, Wang PY, Xiao SQ, Zhang W.

Zhonghua Fu Chan Ke Za Zhi. 2012 Apr;47(4):250-4. Chinese.

PMID:
22781109
9.

Myo-inositol may improve oocyte quality in intracytoplasmic sperm injection cycles. A prospective, controlled, randomized trial.

Papaleo E, Unfer V, Baillargeon JP, Fusi F, Occhi F, De Santis L.

Fertil Steril. 2009 May;91(5):1750-4. doi: 10.1016/j.fertnstert.2008.01.088. Epub 2008 May 7.

PMID:
18462730
10.

Effect of myo-inositol and alpha-lipoic acid on oocyte quality in polycystic ovary syndrome non-obese women undergoing in vitro fertilization: a pilot study.

Rago R, Marcucci I, Leto G, Caponecchia L, Salacone P, Bonanni P, Fiori C, Sorrenti G, Sebastianelli A.

J Biol Regul Homeost Agents. 2015 Oct-Dec;29(4):913-23.

PMID:
26753656
11.

Myo-inositol in patients with polycystic ovary syndrome: a novel method for ovulation induction.

Papaleo E, Unfer V, Baillargeon JP, De Santis L, Fusi F, Brigante C, Marelli G, Cino I, Redaelli A, Ferrari A.

Gynecol Endocrinol. 2007 Dec;23(12):700-3. Epub 2007 Oct 10.

PMID:
17952759
12.

[Effects of inositol on oocyte quality in patients affected with polycystic ovary syndrome].

Ciotta L, Stracquadanio M, Pagano I, Carbonaro A, Palumbo M, Gulino F.

Minerva Ginecol. 2010 Dec;62(6):525-31. Italian.

PMID:
21079574
13.

The effect of FT500 Plus(®) on ovarian stimulation in PCOS women.

Alviggi C, Cariati F, Conforti A, De Rosa P, Vallone R, Strina I, Pivonello R, De Placido G.

Reprod Toxicol. 2016 Jan;59:40-4. doi: 10.1016/j.reprotox.2015.10.014. Epub 2015 Nov 3.

PMID:
26545973
14.

Improvement in quality of oocytes in polycystic ovarian syndrome in programs of in vitro fertilization.

Vartanyan EV, Tsaturova KA, Devyatova EA, Mikhaylyukova AS, Levin VA, Petuhova NL, Markin AV, Steptsova EM.

Gynecol Endocrinol. 2017;33(sup1):8-11. doi: 10.1080/09513590.2017.1399699.

PMID:
29264980
15.

Comparison of the effect of two combinations of myo-inositol and D-chiro-inositol in women with polycystic ovary syndrome undergoing ICSI: a randomized controlled trial.

Mendoza N, Diaz-Ropero MP, Aragon M, Maldonado V, Llaneza P, Lorente J, Mendoza-Tesarik R, Maldonado-Lobon J, Olivares M, Fonolla J.

Gynecol Endocrinol. 2019 Aug;35(8):695-700. doi: 10.1080/09513590.2019.1576620. Epub 2019 Mar 16.

PMID:
30880505
16.

Effects of myo-inositol supplementation on oocyte's quality in PCOS patients: a double blind trial.

Ciotta L, Stracquadanio M, Pagano I, Carbonaro A, Palumbo M, Gulino F.

Eur Rev Med Pharmacol Sci. 2011 May;15(5):509-14.

PMID:
21744744
17.

Insulin sensitiser agents alone and in co-treatment with r-FSH for ovulation induction in PCOS women.

Raffone E, Rizzo P, Benedetto V.

Gynecol Endocrinol. 2010 Apr;26(4):275-80. doi: 10.3109/09513590903366996.

PMID:
20222840
18.

The rationale of the myo-inositol and D-chiro-inositol combined treatment for polycystic ovary syndrome.

Dinicola S, Chiu TT, Unfer V, Carlomagno G, Bizzarri M.

J Clin Pharmacol. 2014 Oct;54(10):1079-92. doi: 10.1002/jcph.362. Epub 2014 Jul 18. Review.

PMID:
25042908
19.

Metabolic and hormonal effects of myo-inositol in women with polycystic ovary syndrome: a double-blind trial.

Costantino D, Minozzi G, Minozzi E, Guaraldi C.

Eur Rev Med Pharmacol Sci. 2009 Mar-Apr;13(2):105-10.

PMID:
19499845

Supplemental Content

Support Center